{"product_id":"mani-pestle-analysis","title":"Mani PESTLE Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eYour Competitive Advantage Starts with This Report\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eUnlock strategic clarity with our Mani PESTLE Analysis—concise, expert-curated insights into the political, economic, social, technological, legal, and environmental forces shaping Mani’s future; perfect for investors and strategists. Buy the full report to access deep-dive analysis, actionable recommendations, and editable charts ready for immediate use.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eolitical factors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGeopolitical Trade Relations and Export Policies\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAs of late 2025 the stability of trade agreements between Japan and key markets is pivotal for MANI, with Japan-US medical device trade valued at roughly $12.6bn in 2024 and tariffs of even 3–5% potentially eroding thin margins on precision instruments.\u003c\/p\u003e\n\u003cp\u003eShifts in diplomatic ties or tariff measures—China accounted for 18% of Japan’s medical exports in 2024—could raise landed costs and reduce MANI’s price competitiveness.\u003c\/p\u003e\n\u003cp\u003eMaintaining market share in the US, EU (Europe ~27% of exports) and China requires active tariff risk management, diversified supply chains, and monitoring of trade policy developments.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGovernment Healthcare Reimbursement Schemes\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePolitical decisions on healthcare budgets and reimbursement rates directly affect hospital and dental clinic purchasing power; Japan's 2024 public healthcare spending was about 11.5% of GDP (~JP¥50 trillion) while several ASEAN markets saw \u0026gt;5% annual health budget growth, altering demand for MANI's high-end tools.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegional Political Stability in Southeast Asia\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eWith manufacturing in Vietnam and Myanmar, regional political stability is critical: Vietnam accounted for about 28% of Mani’s 2024 regional output while Myanmar contributed ~12%, so localized unrest or changes to foreign investment rules could halt batches and raise costs by an estimated 6–10% per disrupted quarter. Mani’s diversified production network and contingency capacity aim to limit revenue impact to under 3% annually if volatility occurs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Regulatory Harmonization Efforts\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eGlobal regulatory harmonization, such as ICH-like initiatives for medical devices and recent talks between FDA, EU MDR authorities, and Japan's PMDA, can cut time-to-market for MANI by 20–30%, reducing duplicated clinical testing and certification costs estimated at $2–5M per product.\u003c\/p\u003e\n\u003cp\u003eAlignment lowers bureaucratic barriers and enables simultaneous market entry across top markets representing ~60% of global medtech revenue, while rising protectionism in some regions risks fragmenting standards and increasing compliance spend.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eHarmonization can reduce time-to-market 20–30%\u003c\/li\u003e\n\u003cli\u003ePer-product certification savings $2–5M\u003c\/li\u003e\n\u003cli\u003eTop harmonized markets ≈60% of medtech revenue\u003c\/li\u003e\n\u003cli\u003eProtectionism increases compliance costs and fragmentation\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInvestment in Public Health Infrastructure\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eGovernment initiatives to modernize hospitals and fund specialized surgery centers boost demand for MANI’s ophthalmic and surgical instruments; WHO reports global surgical volume rising ~40% from 2015–2020, increasing device needs.\u003c\/p\u003e\n\u003cp\u003eState commitments in developing markets (India’s 2024 health budget +11% to INR 1.05 lakh crore) create a steady procurement pipeline favoring high-quality, reliable tools where MANI’s precision engineering is valued.\u003c\/p\u003e\n\u003cp\u003ePublic tenders and aid-funded projects commonly specify ISO-certified instruments, aligning with MANI’s export revenues—company reported 2024 export growth ~8–12% in surgical segments.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003ePublic health upgrades → higher surgical device demand\u003c\/li\u003e\n\u003cli\u003eDeveloping-market budgets (e.g., India 2024 +11%) = steady procurement\u003c\/li\u003e\n\u003cli\u003ePreference for ISO-certified, precision tools benefits MANI’s exports (+8–12% 2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Political-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGeopolitical shifts, supply risks and policy reforms reshaping MANI’s market access\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eTrade\/tariff shifts (US-Japan trade ~$12.6bn in 2024; China 18% of Japan’s med exports) and healthcare budgets (Japan public health ~11.5% GDP; India health budget +11% in 2024) drive MANI’s market access and pricing; Vietnam\/ Myanmar made ~28%\/12% of MANI output in 2024, so political instability can raise costs ~6–10% per disrupted quarter; regulatory harmonization may cut time-to-market 20–30%.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eFactor\u003c\/th\u003e\n\u003cth\u003e2024\/2025 Data\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eUS-Japan medical trade\u003c\/td\u003e\n\u003ctd\u003e$12.6bn (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eChina share of Japan med exports\u003c\/td\u003e\n\u003ctd\u003e18% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eJapan health spend\u003c\/td\u003e\n\u003ctd\u003e~11.5% GDP (~JP¥50T, 2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIndia health budget growth\u003c\/td\u003e\n\u003ctd\u003e+11% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eVietnam \/ Myanmar output (MANI)\u003c\/td\u003e\n\u003ctd\u003e28% \/ 12% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDisruption cost impact\u003c\/td\u003e\n\u003ctd\u003e+6–10% per disrupted quarter\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHarmonization time-to-market\u003c\/td\u003e\n\u003ctd\u003e-20–30%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eExplores how external macro-environmental factors uniquely affect the Mani across six dimensions—Political, Economic, Social, Technological, Environmental, and Legal—each supported by current data and trends to identify risks and opportunities for executives, consultants, and entrepreneurs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA concise, visually segmented Mani PESTLE summary that clarifies external risks and opportunities at a glance, ideal for dropping into presentations or distributing across teams to speed strategic alignment.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eE\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003economic factors\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eForeign Exchange Rate Fluctuations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAs a Japan-based firm heavily reliant on international sales, MANI’s performance is driven by JPY movements versus USD and EUR; in 2025 the yen weakened ~6% vs USD YTD, boosting export competitiveness and lifting repatriated revenues—Q1 forex gains added ~¥8.5bn. A stronger yen would compress margins on dollar\/ euro-denominated sales. MANI uses forwards, options and netting to hedge currency exposure and stabilize cash flows.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Inflation and Raw Material Costs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eRising prices for specialized stainless steel and high-grade alloys have pushed MANI’s COGS up; nickel and chromium surged ~18% and ~12% YoY in 2024, raising input bills for medical instruments. Inflation-driven energy and logistics costs—global container rates remained ~30–40% above 2019 levels in 2024—have elevated operational expenses across MANI’s supply chain. MANI mitigates impacts via manufacturing efficiency gains and strategic sourcing, targeting margin protection while maintaining product quality.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHealthcare Spending Trends in Emerging Markets\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eRising middle classes in Southeast Asia and Latin America are increasing healthcare spend—WHO reports 2019–2023 showed out-of-pocket health expenditure rising and McKinsey estimates elective procedure demand growing 8–12% annually in key markets; this fuels demand for advanced dental and surgical devices. Economic development enables hospitals to invest in premium MANI products, with regional medical device market CAGR projected at ~7–9% through 2025. MANI is reallocating sales resources to these zones to capture share and diversify revenue, where FY2024 growth in APAC\/LatAm accounted for an estimated 18–22% of incremental sales.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInterest Rate Environments and Capital Expenditure\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003ePrevailing interest rates directly affect Mani’s borrowing costs for factory expansion and healthcare clients’ ability to finance equipment; US prime rate rose to 8.5% in 2024, raising capital costs versus 2021–22 lows near 3.25%.\u003c\/p\u003e\n\u003cp\u003eHigh rates tend to push smaller dental practices to defer purchases, slowing adoption of Mani toolkits; surveys in 2024 showed 38% of clinics delayed equipment purchases due to financing costs.\u003c\/p\u003e\n\u003cp\u003eConversely, a stable rate outlook supports long-term investments in automation and R\u0026amp;D, with manufacturing capex in medical device firms rising 6% YoY in 2024 where rates remained predictable.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eHigher rates increase Mani’s cost of capital and reduce clinic demand (38% delayed purchases in 2024)\u003c\/li\u003e\n\u003cli\u003eUS prime at 8.5% in 2024 vs ~3.25% in 2021–22\u003c\/li\u003e\n\u003cli\u003eStable rates correlate with +6% YoY medical device capex in 2024\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLabor Market Dynamics and Wage Growth\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eRising labor costs in Japan (average manufacturing wages up ~3.2% YoY to ¥5.6M in 2024) and higher minimum wages in overseas hubs (e.g., Vietnam +8% to VND 5.5M\/month in 2024) force MANI to balance skilled precision engineers with automation to control COGS.\u003c\/p\u003e\n\u003cp\u003eCompetition for precision talent amid a 2024 shortage in skilled manufacturing technicians (Japan vacancy rate ~2.1%) raises personnel costs that risk squeezing margins unless offset by productivity gains.\u003c\/p\u003e\n\u003cp\u003eMaintaining artisanal quality while automating selective tasks is essential to protect average selling price and brand value into 2026.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eJapan manufacturing wages +3.2% (¥5.6M avg, 2024)\u003c\/li\u003e\n\u003cli\u003eVietnam min wage +8% (VND 5.5M\/month, 2024)\u003c\/li\u003e\n\u003cli\u003eSkilled technician vacancy ~2.1% (Japan, 2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/PESTLE-Content-Economic-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFX boosts repatriation; input inflation and rates squeeze margins, capex mixed\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eFX volatility (JPY -6% vs USD YTD 2025) boosts repatriated revenues; hedging reduces earnings swings. Raw material inflation (nickel +18%, chromium +12% YoY 2024) and logistics (+30–40% vs 2019) raise COGS; efficiency and sourcing mitigate. Higher rates (US prime 8.5% in 2024) dent clinic financing and demand (38% delayed purchases) while stable rates support +6% medical-device capex (2024). Labor: Japan wages +3.2% (¥5.6M), Vietnam min wage +8% (VND5.5M).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eJPY vs USD 2025 YTD\u003c\/td\u003e\n\u003ctd\u003e-6%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNickel YoY 2024\u003c\/td\u003e\n\u003ctd\u003e+18%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eChromium YoY 2024\u003c\/td\u003e\n\u003ctd\u003e+12%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eContainer rates vs 2019\u003c\/td\u003e\n\u003ctd\u003e+30–40%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eUS prime rate 2024\u003c\/td\u003e\n\u003ctd\u003e8.5%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eClinics delaying purchases 2024\u003c\/td\u003e\n\u003ctd\u003e38%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMed-device capex YoY 2024\u003c\/td\u003e\n\u003ctd\u003e+6%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eJapan avg manufacturing wage 2024\u003c\/td\u003e\n\u003ctd\u003e¥5.6M (+3.2%)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eVietnam min wage 2024\u003c\/td\u003e\n\u003ctd\u003eVND5.5M (+8%)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003ePreview Before You Purchase\u003c\/span\u003e\u003cbr\u003eMani PESTLE Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview shown here is the exact Mani PESTLE Analysis document you’ll receive after purchase—fully formatted, professionally structured, and ready to use with no placeholders or edits required.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56751442985337,"sku":"mani-pestle-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/mani-pestle-analysis.png?v=1772231421","url":"https:\/\/matrixbcg.com\/products\/mani-pestle-analysis","provider":"MatrixBCG","version":"1.0","type":"link"}